NgLM. Possible hazards of handling antineoplastic drugs (letter). Pediatrics1970; 46: 648–9.
2.
SieberSMAdamsonRH. Toxicity of antineoplastic agents in man: Chromosomal aberrations, antifertility effects, congenital malformations and carcinogenic potential. Adv Cancer Res1975; 22: 57–69.
3.
HarrisCC. The carcinogenicity of anticancer drugs: A hazard in man. Cancer1976; 37: 1014–23.
4.
AdamsonRHSieberSM. Carcinogenic potential of cancer chemotherapeutic agents in man. Cancer Bull1977; 29: 179.
5.
DonnerAL. Possible risk of working with antineoplastic drugs in horizontal laminar flow hoods (letter). Am J Hosp Pharm1978; 35: 900.
6.
FalckKGrohnPSorsaMVainioHHeinonenEHolstiLR. Mutagenicity in urine of nurses handling cytostatic drugs (letter). Lancet1979; 1: 1250–1.
7.
American Society of Hospital Pharmacists. Disposal of unused anticancer drugs. The Signal1979; May.
8.
KnowlesRSVirdenJE. Handling of injectable antineoplastic agents. Br Med J1980; 281: 589–91.
9.
HarrisonBR. Developing guidelines for working with antineoplastic drugs. Am J Hosp Pharm1981; 38: 1686–93.
10.
NguyenTVTheissJCMatneyTS. Exposure of pharmacy personnel to mutagenic antineoplastic drugs. Cancer Res1982; 42: 4792–6.
11.
NorppaHSorsaMVainioHGrohnPHeinonenEHolstiLNormanE. Increased sister chromatid exchange in frequencies in lymphocytes of nurses handling cytostatic drugs. Scand J Work Environ Health1980; 6: 229–301.
12.
StaianoNGallelliJFAdamsonRHThorgeissonSS. Lack of mutagenic activity in urine from hospital pharmacists admixing antitumor drugs. Lancet1981; 1: 615–6.
13.
AndersonRWPuckettWHJrDanaWJNguyenTVTheissJCMatneyTS. Risk of handling injectable antineoplastic agents. Am J Hosp Pharm1982; 39: 1881–7.
14.
GallelliJF. Evaluating the potential hazard of handling antineoplastic drugs. Am J Hosp Pharm1982; 39: 1877.
15.
Clinical Oncological Society of Australia. Guidelines and recommendations for safe handling of antineoplastic agents. Med J Aust1983; 1: 426–8.
16.
EriksenIL. Handling of cytotoxic drugs: Governmental regulations and practical solutions. Pharm Int1982; 3: 264–7.
17.
ThomsenKMikkelsenHI. Protective capacity of gloves used for handling of nitrogen mustard. Contact Dermatitis1975; 1: 268–9.
18.
TortoriciMP. Precautions followed by personnel involved with the preparation of parenteral antineoplastic medications. Hosp Pharm1980; 15: 293–301.
19.
HoffmanDM. The handling of antineoplastic drugs in a major cancer center. Hosp Pharm1980; 15: 302–4.
20.
LadikCFStoehrGPMaurerMA. Precautionary measures in the preparation of antineoplastics (letter). Am J Hosp Pharm1980; 37: 1184–6.
21.
GousseGCNightingaleCHDionneGP. Biological safety cabinets for chemotherapy preparation (letter). Am J Hosp Pharm1981; 38: 967.
22.
ZimmermanPFLarsenRKBarkleyEWGallelliJF. Recommendations for the safe handling of injectable antineoplastic drug products. Am J Hosp Pharm1981; 38: 1693–5.
23.
National Study Commission on Cytotoxic Exposure. Recommendations for handling cytotoxic agents. Providence, RI: National Study Commission on Cytotoxic Exposure, 1983.
24.
National Study Commission on Cytotoxic Exposure. Consensus responses to unresolved questions concerning cytotoxic agents. Providence, RI: National Study Commission on Cytotoxic Exposure, 1984.
25.
National Study Commission on Cytotoxic Exposure. Recommendations for handling cytotoxic agents. Providence, RI: National Study Commission on Cytotoxic Exposure, 1984.
26.
National Study Commission on Cytotoxic Exposure. Consensus responses to unresolved questions concerning cytotoxic agents. 2nd edition. Providence, RI: National Study Commission on Cytotoxic Exposure, 1986.
27.
National Study Commission on Cytotoxic Exposure. Position statement: Disposal of materials related to the use of cytotoxic agents. Providence, RI: National Study Commission on Cytotoxic Exposure, 1986.
28.
National Study Commission on Cytotoxic Exposure. Work practice guidelines. Preparation of cytotoxic agents. Providence, RI: National Study Commission on Cytotoxic Exposure, 1986.
29.
National Study Commission on Cytotoxic Exposure. Work practice guidelines. Administration of cytotoxic agents. Providence, RI: National Study Commission on Cytotoxic Exposure, 1986.
30.
National Study Commission on Cytotoxic Exposure. Work practice guidelines. Disposal of materials related to the preparation and administration of cytotoxic agents. Providence, RI: National Study Commission on Cytotoxic Exposure, 1986.
31.
National Study Commission on Cytotoxic Exposure. Position statement: The handling of cytotoxic agents by women who are pregnant, attempting to conceive or breastfeeding. Providence, RI: National Study Commission on Cytotoxic Exposure, 1987.
32.
National Study Commission on Cytotoxic Exposure. Recommendations for handling cytotoxic agents. Providence, RI: National Study Commission on Cytotoxic Exposure, 1987.
33.
OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Am J Hosp Pharm1986; 43: 1193–204.